Hoth Therapeutics, Inc. (HOTH) a New York-based biopharmaceutical company, Friday announced that it has been notified by Nasdaq's Listing Qualifications Department that it has regained compliance with the minimum bid price requirement outlined in Listing Rule 5550(a)(2).
The notification comes as the company's common stock maintained a closing bid price of $1.00 or higher for 10 consecutive business days, from January 7 to January 22, 2025.
Currently, HOTH is trading at $1.518 or 3.2720 percent higher on the Nasdaq Capital Market.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.